JAMA: the journal of the American Medical Association

• 

  Año 2014, Vol. 311, Número 4

  • The Accelerated Approval of Oncologic Drugs Lessons From Ponatinib

    Vinay Prasad, Sham Mailankody

    • Resumen
    • Texto completo

    págs. 353-354

    

  • Improving the Drug Development Process More Not Less Randomized Trials

    Benjamin Djulbegovic, Iztok Hozo, John P. A. Ioannidis

    • Resumen
    • Texto completo

    págs. 355-356

    

  • Care Partners and Online Patient Portals

    Urmimala Sarkar, David W. Bates

    • Resumen
    • Texto completo

    págs. 357-358

    

  • Time to Get Over It

    Ellen D. Feld

    • Resumen
    • Texto completo

    págs. 359-360

    

  • Opening the FDA Black Box

    Steven N. Goodman, Rita F. Redberg

    • Resumen
    • Texto completo

    págs. 361-363

    

  • Will Detection of MicroRNA Biomarkers in Blood Improve the Diagnosis and Survival of Patients With Pancreatic Cancer?

    D. J. Buchsbaum, Carlo M. Croce

    • Resumen
    • Texto completo

    págs. 363-365

    

  • Evidence-Based Medicine—An Oral History

    Richard Smith, Drummond Rennie

    • Resumen
    • Texto completo

    págs. 365-367

    

  • Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents, 2005-2012

    Nicholas S. Downing, Jenerius A. Aminawung, Nilay D. Shah, Harlan M. Krumholz

    • Resumen
    • Texto completo

    págs. 368-377

    

  • Scientific and Regulatory Reasons for Delay and Denial of FDA Approval of Initial Applications for New Drugs, 2000-2012

    Leonard V Sacks, Hala H. Shamsuddin, Yuliya I. Yasinskaya, Khaled Bouri

    • Resumen
    • Texto completo

    págs. 378-384

    

  • FDA Approval of Cardiac Implantable Electronic Devices via Original and Supplement Premarket Approval Pathways, 1979-2012

    Benjamin N. Rome, Daniel B. Kramer, Aaron S. Kesselheim

    • Resumen
    • Texto completo

    págs. 385-391

    

  • MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer

    Nicolai A. Schultz, Christian Dehlendorff, Benny V. Jensen, Jon K. Bjerregaard

    • Resumen
    • Texto completo

    págs. 392-404

    

  • How to Use a Subgroup Analysis Users’ Guide to the Medical Literature

    Xin Sun, John P. A. Ioannidis, Thomas Agoritsas

    • Resumen
    • Texto completo

    págs. 405-411

    

  • Exercise-Induced Leg Pain and High Blood Pressure

    Jeffrey W. Olin, Daniella Kadian Dodov

    • Resumen

    págs. 412-413

    

  • Association of Mediterranean Diet With Peripheral Artery Disease The PREDIMED Randomized Trial

    Miguel Ruiz-Canela López, Ramón Estruch Riba

    • Resumen
    • Texto completo

    págs. 415-417

    

  • Hormone Therapy Use and Outcomes in the Women’s Health Initiative Trials

    Eric Roehm

    • Resumen

    págs. 417-417

    

  • Hormone Therapy Use and Outcomes in the Women’s Health Initiative Trials—Reply

    JoAnn E. Manson, Rowan Chlebowski, Aaron K. Aragaki

    • Resumen

    págs. 417-418

    

  • Prevention and Control of Hypertension in Different Countries

    M. Mizanur Rahman, Stuart Gilmour

    • Resumen

    págs. 418-419

    

  • Patient-Reported Outcome Alert Monitoring

    Brett D. Thombs, Carolyn Ells, Lee Black

    • Resumen

    págs. 420-420

    

  • Mutually Assured Destruction

    Adam B. Possner

    • Resumen

    págs. 422-422

    

  • FDA Authorization of Medical Devices

    Jill Jin

    • Resumen

    págs. 435-435